Skip to main content
Press release May 14, 2026

CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

CVRx, Inc. (CVRX)

MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Humana has issued
View original release